30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Nexalin Technology Inc (NXL)

Track

The most recent insider trading activity occurred on September 10, 2025, with a proposed sale of 23,150 shares by Marilyn Elson. Prior to this, significant buying activity was observed in early 2025, primarily by Chief Medical Officer David Owens, and in March 2025 by Sr. VP Carolyn Hamby. Earlier transactions in 2022 involved substantial purchases by Marilyn Elson.
Stock chart
Ticker: NXL Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Elson Marilyn
Associate to Affiliate
1 sale — total 403 USD
Proposed sale 10 Sep 2025
Value US$1,927,389.77 | Price 488.13 | Shares 96,644
Buy 12 Mar 2025
Value US$777,659.07 | Price 152.37 | Shares 14,494
Buy 4 Feb 2025
Value US$3,100.00 | Price 3.10 | Shares 1,000
Buy 4 Feb 2025
Value US$2,980.00 | Price 2.98 | Shares 1,000
Buy 28 Jan 2025
Value US$4,050.00 | Price 2.70 | Shares 1,500
Buy 23 Jan 2025
Value US$2,700.00 | Price 2.70 | Shares 1,000
Buy 13 Jan 2025
Value US$5,000.00 | Price 2.50 | Shares 2,000
Buy 28 Oct 2024
Value US$1,095.00 | Price 2.19 | Shares 500
Buy 13 Aug 2024
Value US$950.00 | Price 0.95 | Shares 1,000
Buy 28 Jun 2024
Value US$1,750.00 | Price 1.75 | Shares 1,000
Buy 18 Jun 2024
Value US$1,149.49 | Price 0.71 | Shares 1,619
Buy 10 Jun 2024
Value US$620.00 | Price 0.62 | Shares 1,000
Buy 10 Jun 2024
Value US$1,300.00 | Price 0.65 | Shares 2,000
Buy 28 Sep 2022
Value US$10,640.00 | Price 1.12 | Shares 9,500
Buy 16 Sep 2022
Value US$149,400.00 | Price 4.15 | Shares 36,000
Buy 16 Sep 2022
Value US$10,375.00 | Price 4.15 | Shares 2,500
Buy 16 Sep 2022
Value US$10,375.00 | Price 4.15 | Shares 2,500
Buy 16 Sep 2022
Value US$10,375.00 | Price 4.15 | Shares 2,500
Buy 16 Sep 2022
Value US$10,375.00 | Price 4.15 | Shares 2,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-09-10 2025-09-10 PrS Proposed sale
1.6
Elson Marilyn

Associate to Affiliate
96,644
488.13
US$1,927,390 		96,644 488.13 US$1,927,390
2025-03-13 2025-03-12 B Purchase
0.5
Shelton Carolyn Hamby

Sr. VP - Quality, Regulatory

Officer
14,494 -46.8%
152.37
US$777,659 		14,494 -46.8% 152.37 US$777,659
2025-02-05 2025-02-04 B Purchase
2.5
Owens David

Chief Medical Officer

Executive Director
5,991 -50.0%
122.70
US$2,659,948 		5,991 -50.0% 122.70 US$2,659,948
2025-02-04 2025-02-04 B Purchase
2.5
Owens David

Chief Medical Officer

Executive Director
1,000 +0.7%
2.98
US$2,980 		1,000 +0.7% 2.98 US$2,980
2025-01-29 2025-01-28 B Purchase
2.5
Owens David

Chief Medical Officer

Executive Director
1,500 +1.0%
2.70
US$4,050 		1,500 +1.0% 2.70 US$4,050
2025-01-24 2025-01-23 B Purchase
2.5
Owens David

Chief Medical Officer

Executive Director
1,000 +0.7%
2.70
US$2,700 		1,000 +0.7% 2.70 US$2,700
2025-01-24 2025-01-13 B Purchase
2.5
Owens David

Chief Medical Officer

Executive Director
2,000 +1.3%
2.50
US$5,000 		2,000 +1.3% 2.50 US$5,000
2024-10-30 2024-10-28 B Purchase
2.5
Owens David

Chief Medical Officer

Executive Director
500 +0.3%
2.19
US$1,095 		500 +0.3% 2.19 US$1,095
2024-08-15 2024-08-13 B Purchase
2.5
Owens David

Chief Medical Officer

Executive Director
1,000 +0.7%
0.95
US$950 		1,000 +0.7% 0.95 US$950
2024-07-01 2024-06-28 B Purchase
2.5
Owens David

Chief Medical Officer

Executive Director
1,000 +0.7%
1.75
US$1,750 		1,000 +0.7% 1.75 US$1,750
2024-06-21 2024-06-18 B Purchase
2.5
Owens David

Chief Medical Officer

Executive Director
1,619 +1.1%
0.71
US$1,149 		1,619 +1.1% 0.71 US$1,149
2024-06-12 2024-06-10 B Purchase
2.5
Owens David

Chief Medical Officer

Executive Director
1,000 +0.7%
0.62
US$620 		1,000 +0.7% 0.62 US$620
2024-06-12 2024-06-10 B Purchase
2.5
Owens David

Chief Medical Officer

Executive Director
2,000 +1.4%
0.65
US$1,300 		2,000 +1.4% 0.65 US$1,300
2022-09-29 2022-09-28 B Purchase
1.6
Elson Marilyn

Ms. Elson serves as CFO

Officer Large shareholder
9,500 +1.2%
1.12
US$10,640 		9,500 +1.2% 1.12 US$10,640
2022-09-20 2022-09-16 B Purchase
1.6
Elson Marilyn

Ms. Elson serves as CFO

Officer Large shareholder
36,000 +4.6%
4.15
US$149,400 		36,000 +4.6% 4.15 US$149,400
2022-09-20 2022-09-16 B Purchase
Kazden Alan
Non-Executive Director
2,500 +2.9%
4.15
US$10,375 		2,500 +2.9% 4.15 US$10,375
2022-09-20 2022-09-16 B Purchase
White Mark

President/CEO

Executive Director
2,500 +0.9%
4.15
US$10,375 		2,500 +0.9% 4.15 US$10,375
2022-09-20 2022-09-16 B Purchase
Morad Rick
Non-Executive Director
2,500 +2.4%
4.15
US$10,375 		2,500 +2.4% 4.15 US$10,375
2022-09-20 2022-09-16 B Purchase
2.5
Owens David

Chief Medical Officer

Executive Director
2,500 +1.8%
4.15
US$10,375 		2,500 +1.8% 4.15 US$10,375
Explore more

More insider trading research around Nexalin Technology Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America